Functional coding and non-coding variants in human BRCA1 gene and their use in genetic screening.

Area of Science:

• Genetics
• Molecular Biology
• Oncology

Background:

• The BRCA1 gene is crucial for DNA double-strand break repair.
• Mutations in BRCA1 are linked to hereditary breast and ovarian cancers.
• High-throughput sequencing identifies numerous genetic variants in BRCA1.

Purpose of the Study:

• To highlight the importance of determining the functional impact of detected BRCA1 variants.
• To emphasize the necessity of predictive software and family history in interpreting genetic screening results.
• To underscore the significance of in silico and in vitro methods for assessing variant pathogenicity.

Main Methods:

• Utilizing high-throughput DNA sequencing techniques.
• Employing predictive software for variant analysis.
• Applying in silico and in vitro methods for pathogenicity scoring.

Main Results:

• Numerous single-nucleotide polymorphisms (SNPs) and insertion/deletion (Indel) mutations are detected in BRCA1.
• BRCA1 mutations can alter protein function or gene expression, leading to pathogenic or benign effects.
• Accurate interpretation of screening results necessitates understanding variant pathogenicity.

Conclusions:

• Precise analysis of genetic screening tests for BRCA1 requires pathogenicity assessment of detected variants.
• In silico and in vitro techniques are vital for accurately interpreting BRCA1 mutation effects.
• Reliable patient counseling and risk assessment depend on precise variant analysis.